Vivo Ventures LLC closed its seventh fund after raising $375 million.
The Palo Alto firm plans to invest the money in drug and medical device companies in the later stages of development in the United States. It also plans to put money into healthcare companies that are already bringing in revenue in China.
No comments:
Post a Comment